Valuation : Evolutionary Genomics, Inc.

Market Cap 2.99M 2.58M 2.43M 2.21M 4.16M 284M 4.19M 28.73M 11.18M 145M 11.24M 11M 479M P/E 2021
-1.34x
P/E 2022 -2x
Enterprise Value 6.16M 5.31M 5M 4.55M 8.56M 585M 8.61M 59.1M 23M 297M 23.13M 22.63M 986M EV / Sales 2021
-
EV / Sales 2022 -
Free-Float
67.35%
Yield 2021 *
-
Yield 2022 -
1 year 0
Extreme 0.0002
0
3 years 0
Extreme 0.0002
0
5 years 0
Extreme 0.0002
0.9
10 years 0
Extreme 0.0002
5.71
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 71 01/01/2000
Chief Executive Officer 70 01/10/2014
Director TitleAgeSince
Chairman 70 01/10/2014
Director/Board Member 76 01/01/2000
Director/Board Member 66 01/01/2010
Date Insider Type Main position Quantity % Market Cap. Importance
23/05/22 Exercice

Chief Executive Officer

185,715 2.8074%
23/05/22 Exercice

Founder

278,571 4.2111%
23/05/22 Exercice

Founder

55,714 0.8422%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-99.96% 1.33K
+0.66%-1.02%+3.23%+17.46% 49.74B
+2.09%-0.71%+452.73%+498.77% 44.98B
-1.09%-0.41%+35.40%+15.17% 42.52B
-0.26%-4.71%+17.19%+71.67% 40.78B
-0.48%-0.84%+16.25%+49.80% 32.89B
-1.06%+2.87% - - 17.09B
-1.81%-5.02%+22.65%+113.24% 16.28B
+0.22%-1.51%+16.81%+26.22% 14.4B
-2.05%-5.14%+72.89%+34.69% 13.48B
Average -0.54%-2.20%+70.79%+80.79% 27.22B
Weighted average by Cap. -0.33%-2.27%+97.46%+122.31%

Financials

2021 2022
Net sales - -
Net income -2.79M -2.41M -2.27M -2.07M -3.88M -265M -3.9M -26.8M -10.43M -135M -10.49M -10.26M -447M -1.93M -1.67M -1.57M -1.43M -2.69M -184M -2.7M -18.56M -7.22M -93.41M -7.26M -7.11M -310M
Net Debt 3.53M 3.04M 2.86M 2.61M 4.91M 335M 4.93M 33.86M 13.18M 170M 13.25M 12.97M 565M 3.17M 2.73M 2.57M 2.34M 4.4M 301M 4.43M 30.38M 11.82M 153M 11.89M 11.63M 507M
Logo Evolutionary Genomics, Inc.
Evolutionary Genomics, Inc. is a genomics research and development company. The Company is focused on the identification and validation of genes that impact commercially valuable traits in crops for the agriculture industry. It has performed research on crops including rice, corn, soybeans, wheat, cotton, cowpeas, beans, tomatoes, and cassava. Its core technology is its patented Adapted Traits Platform (ATP), which is used to perform molecular evolution analysis to identify positively selected genes that may have an impact on traits of interest. Positively selected candidate genes must be further tested to validate their impact on the desired traits. The Company has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes and cotton.
Employees
3
  1. Stock Market
  2. Stocks
  3. FNAM Stock